Literature DB >> 16730656

Study of hyaluronan synthase inhibitor, 4-methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL).

Hajime Morohashi1, Atsushi Kon, Makoto Nakai, Masanori Yamaguchi, Ikuko Kakizaki, Shuichi Yoshihara, Mutsuo Sasaki, Keiichi Takagaki.   

Abstract

The structure of 4-methylumbelliferone (MU) consists of coumarin with 4-methyl group and 7-hydroxy group. MU inhibits HA synthesis and pericellular HA matrix formation. In this study, we used 10 MU derivatives which have hydroxy groups and methyl groups at various positions of coumarin to investigate a more effective HA inhibitor than MU. First, human pancreatic cancer cell (KP1-NL) growth assay was analyzed by Alamar Blue to determine the non-toxic concentration of MU derivatives, and the inhibitory effect on HA synthesis in the cell cultures was analyzed by HA measuring kit. Next, cell surfaces of cancer cells were analyzed by particle-exclusion assay. In conclusion, both hydroxy and methyl groups are necessary for HA inhibition by MU, and two hydroxy groups inhibited HA synthesis more strongly than MU.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730656     DOI: 10.1016/j.bbrc.2006.05.037

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.

Authors:  Vinata B Lokeshwar; Luis E Lopez; Daniel Munoz; Andrew Chi; Samir P Shirodkar; Soum D Lokeshwar; Diogo O Escudero; Neetika Dhir; Norman Altman
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

2.  Cyclic movement stimulates hyaluronan secretion into the synovial cavity of rabbit joints.

Authors:  K R Ingram; A K T Wann; C K Angel; P J Coleman; J R Levick
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

3.  Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan.

Authors:  Aditya G Kohli; Saul Kivimäe; Matthew R Tiffany; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-20       Impact factor: 9.776

4.  Hyaluronan synthesis mediates the fibrotic response of keratocytes to transforming growth factor beta.

Authors:  Naxin Guo; Xuan Li; Mary M Mann; Martha L Funderburgh; Yiqin Du; James L Funderburgh
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

5.  Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.

Authors:  Mariana Malvicini; Esteban Fiore; Valentina Ghiaccio; Flavia Piccioni; Miguel Rizzo; Lucila Olmedo Bonadeo; Mariana García; Marcelo Rodríguez; Juan Bayo; Estanislao Peixoto; Catalina Atorrasagasti; Laura Alaniz; Jorge Aquino; Pablo Matar; Guillermo Mazzolini
Journal:  Mol Ther       Date:  2015-06-24       Impact factor: 11.454

Review 6.  Hyaluronic acid in digestive cancers.

Authors:  Ruo-Lin Wu; Lei Huang; Hong-Chuan Zhao; Xiao-Ping Geng
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-17       Impact factor: 4.553

Review 7.  Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery.

Authors:  Aaron Dolor; Francis C Szoka
Journal:  Mol Pharm       Date:  2018-05-16       Impact factor: 4.939

Review 8.  Hyaluronan and hyaluronidase in genitourinary tumors.

Authors:  Melanie A Simpson; Vinata B Lokeshwar
Journal:  Front Biosci       Date:  2008-05-01

9.  Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer.

Authors:  Kazuhiro Nouso; Maho Amano; Yoichi M Ito; Koji Miyahara; Yuki Morimoto; Hironari Kato; Koichiro Tsutsumi; Takeshi Tomoda; Naoki Yamamoto; Shinichiro Nakamura; Sayo Kobayashi; Kenji Kuwaki; Hiroaki Hagihara; Hideki Onishi; Yasuhiro Miyake; Fusao Ikeda; Hidenori Shiraha; Akinobu Takaki; Taku Nakahara; Shin-Ichiro Nishimura; Kazuhide Yamamoto
Journal:  J Gastroenterol       Date:  2013-01-11       Impact factor: 7.527

10.  Inhibition of hyaluronan secretion by novel coumarin compounds and chitin synthesis inhibitors.

Authors:  Alexandra A Tsitrina; Igor V Krasylov; Dmitry I Maltsev; Irina N Andreichenko; Viktoria S Moskvina; Dmitry N Ivankov; Elena V Bulgakova; Mikhail Nesterchuk; Vera Shashkovskaya; Nataliya O Dashenkova; Vladimir P Khilya; Arsen Mikaelyan; Yuri Kotelevtsev
Journal:  Glycobiology       Date:  2021-09-09       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.